131 related articles for article (PubMed ID: 26012319)
1. QT interval prolongation: a risk factor for development of hepatorenal syndrome in cirrhotic patients with acute variceal bleeding.
Peter G; George PC; Villyoth MP; Sivaraman S; Hamza RE; Bahuleyan S; Srijith K; Haridas A; Abdul Sathar S; Sreesh S; Narayanan P; Vinayakumar KR
Trop Gastroenterol; 2014; 35(3):157-63. PubMed ID: 26012319
[TBL] [Abstract][Full Text] [Related]
2. QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis.
Trevisani F; Di Micoli A; Zambruni A; Biselli M; Santi V; Erroi V; Lenzi B; Caraceni P; Domenicali M; Cavazza M; Bernardi M
Liver Int; 2012 Nov; 32(10):1510-5. PubMed ID: 22776742
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.
Biselli M; Gramenzi A; Lenzi B; Dall'Agata M; Pierro ML; Perricone G; Tonon M; Bellettato L; D'Amico G; Angeli P; Boffelli S; Bonavita ME; Domenicali M; Caraceni P; Bernardi M; Trevisani F
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1388-1397.e1. PubMed ID: 30557740
[TBL] [Abstract][Full Text] [Related]
4. Terlipressin improves pulmonary pressures in cirrhotic patients with pulmonary hypertension and variceal bleeding or hepatorenal syndrome.
Kalambokis GN; Pappas K; Tsianos EV
Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):434-7. PubMed ID: 22893473
[TBL] [Abstract][Full Text] [Related]
5. Variceal pressure is a strong predictor of variceal haemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension.
El Atti EA; Nevens F; Bogaerts K; Verbeke G; Fevery J
Gut; 1999 Oct; 45(4):618-21. PubMed ID: 10486375
[TBL] [Abstract][Full Text] [Related]
6. Predictive factor for hepatic encephalopathy in cirrhotic patients who presented with acute variceal bleeding.
Rattanasupar A; Tiawijit N; Rachatapantanakorn B
J Med Assoc Thai; 2014 Jun; 97(6):567-73. PubMed ID: 25137873
[TBL] [Abstract][Full Text] [Related]
7. C-reactive Protein Can Predict Patients with Cirrhosis at a High Risk of Early Mortality after Acute Esophageal Variceal Bleeding.
Ichikawa T; Machida N; Kaneko H; Oi I; A Fujino M
Intern Med; 2019 Feb; 58(4):487-495. PubMed ID: 30333404
[TBL] [Abstract][Full Text] [Related]
8. Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure.
Kayacetin E; Efe D; Doğan C
J Gastroenterol; 2004 Jul; 39(7):661-7. PubMed ID: 15293137
[TBL] [Abstract][Full Text] [Related]
9. Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.
Nevens F; Bittencourt PL; Coenraad MJ; Ding H; Hou MC; Laterre PF; Mendizabal M; Ortiz-Olvera NX; Vorobioff JD; Zhang W; Angeli P
Dig Dis Sci; 2019 Jun; 64(6):1419-1431. PubMed ID: 30684079
[TBL] [Abstract][Full Text] [Related]
10. Complications of cirrhosis.
Rahimi RS; Rockey DC
Curr Opin Gastroenterol; 2012 May; 28(3):223-9. PubMed ID: 22343347
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
Krag A; Borup T; Møller S; Bendtsen F
Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
[TBL] [Abstract][Full Text] [Related]
12. Hemorheology in patients with liver cirrhosis: special emphasis on its relation to severity of esophageal variceal bleeding.
Liu TT; Wong WJ; Hou MC; Lin HC; Chang FY; Lee SD
J Gastroenterol Hepatol; 2006 May; 21(5):908-13. PubMed ID: 16704544
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic analysis of esophageal varices in patients with liver cirrhosis using color Doppler ultrasound.
Li FH; Hao J; Xia JG; Li HL; Fang H
World J Gastroenterol; 2005 Aug; 11(29):4560-5. PubMed ID: 16052688
[TBL] [Abstract][Full Text] [Related]
14. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
[TBL] [Abstract][Full Text] [Related]
15. Propranolol can correct prolonged QT intervals in patients with cirrhosis.
Han H; Chen J; Deng Z; Li T; Qi X; Deng W; Wu Z; Xiao C; Zheng W; Du Y
Front Pharmacol; 2024; 15():1370261. PubMed ID: 38738176
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis.
Zambruni A; Trevisani F; Di Micoli A; Savelli F; Berzigotti A; Bracci E; Caraceni P; Domenicali M; Felline P; Zoli M; Bernardi M
J Hepatol; 2008 Mar; 48(3):415-21. PubMed ID: 18194821
[TBL] [Abstract][Full Text] [Related]
17. Corrected QT interval and QT dispersion in cirrhotic patients before and after liver transplantation.
Zamirian M; Tavassoli M; Aghasadeghi K
Arch Iran Med; 2012 Jun; 15(6):375-7. PubMed ID: 22642249
[TBL] [Abstract][Full Text] [Related]
18. Alcohol consumption and risk of infection after a variceal bleeding in low-risk patients.
Conejo I; Augustin S; Pons M; Ventura-Cots M; González A; Esteban R; Genescà J
Liver Int; 2016 Jul; 36(7):994-1001. PubMed ID: 26643867
[TBL] [Abstract][Full Text] [Related]
19. QTc interval prolongation in liver cirrhosis with upper gastrointestinal bleeding.
Ou M; Tian Y; Zhuang G; Peng Y
Med Clin (Barc); 2021 Jan; 156(2):68-75. PubMed ID: 33309043
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis.
Kerbert AJ; Chiang FW; van der Werf M; Stijnen T; Slingerland H; Verspaget HW; van Hoek B; Coenraad MJ
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):380-387. PubMed ID: 28002118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
